Security Snapshot

Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) Institutional Ownership

CUSIP: 64131A105

13F Institutional Holders and Ownership History from Q2 2018 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

95

Shares (Excl. Options)

42,321,445

Price

$1.38

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
STIM on Nasdaq
Shares outstanding
69,254,377
Price per share
$1.39
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
42,321,445
Total reported value
$58,403,556
% of total 13F portfolios
0%
Share change
+2,582,741
Value change
+$2,440,644
Number of holders
95
Price from insider filings
$1.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • STIM - Neuronetics, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 64131A105.
  • 95 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 95 to 16 between Q4 2025 and Q1 2026.
  • Reported value moved from $58,403,556 to $1,326,889.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 95 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 64131A105?
CUSIP 64131A105 identifies STIM - Neuronetics, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Madryn Asset Management, LP 30% -3.5% $32,764,556 20,737,061 0% MADRYN ASSET MANAGEMENT, LP 02 Mar 2026
Chernett Jorey 14% 0% $14,381,561 9,778,718 0% Chernett Jorey 06 Apr 2026

As of 31 Dec 2025, 95 institutional investors reported holding 42,321,445 shares of Neuronetics, Inc. - Common Stock, $0.01 par value (STIM). This represents 61% of the company’s total 69,254,377 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Madryn Asset Management, LP 27% 18,475,893 0% 73% $25,496,732
UBS Group AG 3.8% 2,607,047 +20% 0% $3,597,725
VANGUARD GROUP INC 3.7% 2,582,382 -8.8% 0% $3,563,687
Balyasny Asset Management L.P. 3.7% 2,552,404 +40% 0.01% $3,522,318
BlackRock, Inc. 3.4% 2,353,751 +2.2% 0% $3,248,177
Lane Generational LLC 2.5% 1,705,197 2.1% $2,353,172
JANE STREET GROUP, LLC 1.5% 1,017,862 +334% 0% $1,404,650
MASTERS CAPITAL MANAGEMENT LLC 1.4% 1,000,000 0% 0.19% $1,380,000
FourWorld Capital Management LLC 1.3% 931,250 +64% 1.2% $1,285,125
GEODE CAPITAL MANAGEMENT, LLC 1.3% 891,733 +1.7% 0% $1,230,805
Ikarian Capital, LLC 1% 701,182 -23% 0.13% $967,631
WEXFORD CAPITAL LP 0.93% 644,951 -45% 0.23% $890,030
STATE STREET CORP 0.84% 584,167 -0.59% 0% $806,150
HighTower Advisors, LLC 0.81% 564,306 -2.2% 0% $778,742
RENAISSANCE TECHNOLOGIES LLC 0.69% 474,900 0% $655,362
GOLDMAN SACHS GROUP INC 0.48% 331,954 +50% 0% $458,096
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.46% 321,561 +46% 0% $443,754
XTX Topco Ltd 0.45% 314,194 +993% 0.01% $433,588
MARSHALL WACE, LLP 0.41% 286,045 -69% 0% $394,743
NORTHERN TRUST CORP 0.4% 278,400 +0.65% 0% $384,192
AdvisorShares Investments LLC 0.39% 270,916 +43% 0.06% $373,864
JBF Capital, Inc. 0.34% 233,166 0.05% $321,769
Massar Capital Management, LP 0.32% 221,000 -7.9% 0.06% $304,980
TWO SIGMA INVESTMENTS, LP 0.29% 198,745 -41% 0% $274,268
BOOTHBAY FUND MANAGEMENT, LLC 0.25% 175,000 -37% 0.01% $241,500

Institutional Holders of Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 915,093 $1,326,889 +$631,664 $1.45 16
2025 Q4 42,321,445 $58,403,556 +$2,440,644 $1.38 95
2025 Q3 21,232,802 $58,049,218 +$7,340,536 $2.73 98
2025 Q2 18,093,968 $63,148,166 +$3,129,708 $3.49 88
2025 Q1 17,062,115 $62,803,548 +$35,157,851 $3.68 97
2024 Q4 7,530,429 $12,132,539 -$1,420,510 $1.61 42
2024 Q3 10,580,181 $8,052,445 -$13,944,974 $0.76 44
2024 Q2 17,514,972 $31,525,823 -$913,690 $1.80 65
2024 Q1 17,686,789 $84,186,603 +$9,049,608 $4.76 64
2023 Q4 15,922,894 $46,174,457 -$4,038,844 $2.90 65
2023 Q3 17,365,514 $23,442,312 -$2,414,040 $1.35 54
2023 Q2 17,946,652 $38,585,361 -$1,638,264 $2.15 69
2023 Q1 18,435,060 $53,643,107 -$628,420 $2.91 74
2022 Q4 17,541,685 $120,448,453 +$11,139,196 $6.87 82
2022 Q3 17,121,046 $54,359,566 -$973,632 $3.18 73
2022 Q2 17,426,518 $56,389,919 -$7,205,201 $3.21 72
2022 Q1 19,730,409 $59,879,991 -$1,519,450 $3.03 81
2021 Q4 19,985,187 $88,986,241 -$15,135,210 $4.46 77
2021 Q3 21,315,432 $139,872,997 -$55,373,438 $6.56 94
2021 Q2 23,330,466 $373,704,997 +$47,745,072 $16.02 105
2021 Q1 20,737,501 $256,439,000 +$112,752,659 $12.37 80
2020 Q4 11,650,490 $129,426,000 +$8,081,210 $11.11 58
2020 Q3 12,101,988 $58,827,000 +$11,426,082 $4.86 53
2020 Q2 10,812,204 $20,868,577 -$2,710,306 $1.93 52
2020 Q1 12,223,726 $23,102,925 -$8,001,640 $1.89 59
2019 Q4 13,218,553 $59,347,854 -$10,619,599 $4.49 68
2019 Q3 14,663,382 $121,924,326 +$559,570 $8.31 65
2019 Q2 14,778,107 $184,734,102 +$1,320,908 $12.51 58
2019 Q1 14,545,951 $221,820,840 +$31,464,217 $15.25 64
2018 Q4 12,321,242 $238,413,000 -$12,246,834 $19.35 60
2018 Q3 11,955,579 $383,291,000 +$43,186,695 $32.06 73
2018 Q2 10,782,424 $286,911,000 +$286,911,000 $26.61 68
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .